Clin Mol Hepatol.
2025 Apr;31(2):599-602. 10.3350/cmh.2024.1133.
Circulating cell-free mitochondrial DNA for diagnosing hepatocellular carcinoma and assessing prognosis: Editorial on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”
- Eun Hs
1,2
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea
- 2Department of Internal Medicine, Chungnam National University College of Medicine and Graduate School of Medicine, Daejeon, Korea
- KMID: 2566983
- DOI: http://doi.org/10.3350/cmh.2024.1133
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Correspondence to editorial on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”
- Reply to correspondence on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”
- Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma
- Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
- Exploring the prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma
